The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Hepatic artery infusion for recurrent or chemotherapy-resistant hepatic malignancy.
H. J. Wanebo
No relevant relationships to disclose
S. R. Sanikommu
No relevant relationships to disclose
C. Taneja
No relevant relationships to disclose
G. Begossi
No relevant relationships to disclose
F. J. Cummings
No relevant relationships to disclose
J. Belliveau
No relevant relationships to disclose